522 Results

People

  1. De Angelis
    De Angelis
  2. Kris
    Kris
  3. Motzer
    Motzer
  4. Livingston
    Livingston
  5. Aghajanian
    Aghajanian
  6. Krown
    Krown
  7. Panageas
    Panageas
  8. Miller
    Miller
  9. Tyson
    Tyson
  10. Vickers
    Vickers

Groups

  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)
  7. Tow Center for Developmental Oncology (TCDO) (51)
  8. Epidemiology and Biostatistics (49)
  9. Population Sciences Research Program (45)
  10. Genitourinary Oncology Service (41)
  1. "headache"
Formats
  1. Journal Article (491)
  2. Review (17)
  3. Research Letter (5)
  4. Conference Paper (3)
  5. Editorial (3)
  6. Book Whole (1)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)

More Groups

People
  1. Lisa De Angelis (20)
  2. Mark Kris (20)
  3. Robert Motzer (19)
  4. Philip Livingston (13)
  5. Carol Aghajanian (12)
  6. Katherine Panageas (12)

More People

Years
  1. 2025 (15)
  2. 2024 (34)
  3. 2023 (30)
  4. 2022 (16)
  5. 2021 (18)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Clinical Cancer Research (23)
  3. Lancet Oncology (20)
  4. Blood (18)
  5. New England Journal of Medicine (17)
  6. Cancer (16)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Elsevier Science, Inc. (43)
  3. Springer (42)
  4. American Society of Clinical Oncology (37)
  5. Nature Publishing Group (32)
  6. Oxford University Press (29)

More Publishers

Results (522)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Juxtaglomerular cell tumor: A rare, curable cause of hypertension in a young patient
    Journal Article

    Walasek, A.; Gupta, S.; Fine, S.; Russo, P.
    Urology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of dabrafenib in pediatric patients with BRAF V600 mutation–positive relapsed or refractory low-grade glioma: Results from a phase I/IIa study
    Journal Article

    Hargrave, D. R.; Bouffet, E.; Tabori, U.; Broniscer, A.; Cohen, K. J.; Hansford, J. R.; Geoerger, B.; Hingorani, P.; Dunkel, I. J.; Russo, M. W.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Surgical resection of granular cell tumor of the sellar region: Three indications
    Journal Article

    Ahmed, A. K.; Dawood, H. Y.; Cote, D. J.; Bale, T. A.; De Girolami, U.; Laws, E. R. Jr; Smith, T. R.
    Pituitary (2019)

    Fulltext@MSK | Save
  • Clinical utilization of chimeric antigen receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL) - An expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
    Editorial

    Kansagra, A. J.; Frey, N. V.; Bar, M.; Laetsch, T. W.; Carpenter, P. A.; Savani, B. N.; Heslop, H. E.; Bollard, C. M.; Komanduri, K. V.; Gastineau, D. A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
    Journal Article

    Yacoub, A.; Mascarenhas, J.; Kosiorek, H.; Prchal, J. T.; Berenzon, D.; Baer, M. R.; Ritchie, E.; Silver, R. T.; Kessler, C.; Winton, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): A multicentre, multicohort, open-label, phase 1b trial
    Journal Article

    Naing, A.; Wong, D. J.; Infante, J. R.; Korn, W. M.; Aljumaily, R.; Papadopoulos, K. P.; Autio, K. A.; Pant, S.; Bauer, T. M.; Drakaki, A.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML
    Journal Article

    Perl, A. E.; Martinelli, G.; Cortes, J. E.; Neubauer, A.; Berman, E.; Paolini, S.; Montesinos, P.; Baer, M. R.; Larson, R. A.; Ustun, C.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201
    Journal Article

    Chi, A. S.; Tarapore, R. S.; Hall, M. D.; Shonka, N.; Gardner, S.; Umemura, Y.; Sumrall, A.; Khatib, Z.; Mueller, S.; Kline, C.; more...
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): A phase 3, multicentre, open-label, single-arm trial
    Journal Article

    Fleseriu, M.; Pivonello, R.; Elenkova, A.; Salvatori, R.; Auchus, R. J.; Feelders, R. A.; Geer, E. B.; Greenman, Y.; Witek, P.; Cohen, F.; more...
    Lancet Diabetes & Endocrinology (2019)

    Fulltext@MSK | Save
  • Effect of aging and predonation comorbidities on the related peripheral blood stem cell donor experience: Report from the Related Donor Safety Study
    Journal Article

    Pulsipher, M. A.; Logan, B. R.; Chitphakdithai, P.; Kiefer, D. M.; Riches, M. L.; Rizzo, J. D.; Anderlini, P.; Leitman, S. F.; Varni, J. W.; Kobusingye, H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save